Nora Therapeutics, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 2007-01-01
- Employees
- 11
- Market Cap
- -
Clinical Trials
3
Active:0
Completed:2
Trial Phases
1 Phases
Phase 2:3
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials
Phase 2
3 (100.0%)A Multi-center, Placebo-controlled Study to Evaluate NT100 in Pregnant Women With a History of Unexplained Recurrent Pregnancy Loss (RPL)
- First Posted Date
- 2014-06-05
- Last Posted Date
- 2015-07-15
- Lead Sponsor
- Nora Therapeutics, Inc.
- Target Recruit Count
- 150
- Registration Number
- NCT02156063
Follow-Up Of Pregnancies Established During Study NT-03 (Thrive-IVF Follow-Up)
Phase 2
Completed
- Conditions
- Repeated IVF Failure
- First Posted Date
- 2013-11-07
- Last Posted Date
- 2015-09-14
- Lead Sponsor
- Nora Therapeutics, Inc.
- Target Recruit Count
- 40
- Registration Number
- NCT01978561
A Multi-Center Study To Evaluate Multiple Doses of NT100 Following IVF In Women With Repeated IVF Failures (Thrive-IVF)
- First Posted Date
- 2013-05-29
- Last Posted Date
- 2014-11-20
- Lead Sponsor
- Nora Therapeutics, Inc.
- Target Recruit Count
- 157
- Registration Number
- NCT01864356
- Locations
- 🇺🇸
HRC Fertility, Pasadena, California, United States
🇺🇸UCSF, San Francisco, California, United States
🇺🇸Reproductive Associates of Delaware, Newark, Delaware, United States
News
No news found